Matches in Nanopublications for { ?s ?p "[Differential expression of both SPRY4 and SPRY4-IT1 was also detected in vivo, in 30 distinct patient samples, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP241562.RAytu-nZgJtsCHl2wxOYkUU1g1iqZShqSNdd2k33hx63o130_assertion description "[Differential expression of both SPRY4 and SPRY4-IT1 was also detected in vivo, in 30 distinct patient samples, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP241562.RAytu-nZgJtsCHl2wxOYkUU1g1iqZShqSNdd2k33hx63o130_provenance.
- NP457781.RAPD99yZvP_bM---BxTW7w3V8m2lxa40YwYGqPBW9wO7c130_assertion description "[Differential expression of both SPRY4 and SPRY4-IT1 was also detected in vivo, in 30 distinct patient samples, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP457781.RAPD99yZvP_bM---BxTW7w3V8m2lxa40YwYGqPBW9wO7c130_provenance.
- NP952142.RAijLSSDeKEmI9vpVHHQS2Ix1n6eyOqIlHLRH1INR_XHQ130_assertion description "[Differential expression of both SPRY4 and SPRY4-IT1 was also detected in vivo, in 30 distinct patient samples, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952142.RAijLSSDeKEmI9vpVHHQS2Ix1n6eyOqIlHLRH1INR_XHQ130_provenance.
- assertion description "[Differential expression of both SPRY4 and SPRY4-IT1 was also detected in vivo, in 30 distinct patient samples, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP893012.RACE6ewuAzJimniMSvnlgDD-4HcWmWVWwQk0MONaTuhpM130_assertion description "[Differential expression of both SPRY4 and SPRY4-IT1 was also detected in vivo, in 30 distinct patient samples, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893012.RACE6ewuAzJimniMSvnlgDD-4HcWmWVWwQk0MONaTuhpM130_provenance.
- NP893010.RAF76woYTdpBIvYw4FWtoueLNjjQKYmjzWZMP3RfDtXxo130_assertion description "[Differential expression of both SPRY4 and SPRY4-IT1 was also detected in vivo, in 30 distinct patient samples, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893010.RAF76woYTdpBIvYw4FWtoueLNjjQKYmjzWZMP3RfDtXxo130_provenance.
- NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_assertion description "[Differential expression of both SPRY4 and SPRY4-IT1 was also detected in vivo, in 30 distinct patient samples, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_provenance.